Category: Recent posts
-
Enroll in MIT xPro Course through March 3rd!
Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists, chemists, researchers, program managers, and…
-
BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.
BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody treatments affordable and available, particularly…
-
BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations
CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the…
-
NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020
On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP) (CMS-2482-P). With active input from…
-
BioACCESS Receives Funding to Contribute to IBM Watson’s Initiative: Marshalling AI in the Fight Against COVID-19
The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic, including BioACCESS’ Overcoming manufacturing and…
-
Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies
This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating biopharmaceutical manufacturing processes. Read the…
-
Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020
In response to the COVID-19 pandemic, the Center for Biomedical Innovation has hosted a series of collaborative webinars focused on how the biomanufacturing industry is…
-
BioACCESS Attends WHO Summit on Noncommunicable Diseases
Donovan Guttieres, a research scientist on the BioACCESS initiative, was awarded a grant to attend the Global Meeting to Accelerate Progress on SDG Target 3.4…
-
Evidera Interviews MIT CBI’s Gigi Hirsch, MD
Dr. Debra Schaumberg, Vice President, Scientific Affairs, Real-World Evidence at Evidera recently sat down with Dr. Hirsch to discuss the NEWDIGS initiative, the LEAPS project,…
-
The Singapore-MIT Alliance for Research and Technology announces a new effort in cell therapy manufacturing, CAMP!!
CBI will work on one of three flagship research projects under the Singapore-MIT Alliance for Research and Technology’s new program on Critical Analytics for Manufacturing…